Outpatient Hospital Services / Compliance Tips and Tools / Avoid Clinical-Trial Risk Areas

Why This Topic Matters

Clinical-trial activity can create significant billing, disclosure, and oversight exposure if hospital, research, and sponsor responsibilities are not clearly separated. This article helps readers identify the general compliance areas that may require coordination between clinical, billing, and research operations.

Article Sections

1. Clinical-trial risk areas

   An overview of common compliance concerns that can arise when hospitals participate in clinical research. The section frames the major oversight and billing issues discussed in the article.

2. Double billing

   Discusses the risk of billing overlap between sponsored research arrangements and routine reimbursement pathways. It also addresses the need for coordination among research, compliance, and billing functions.

3. Experimental products

   Covers compliance concerns related to trial-related drugs, devices, and related hospital billing processes. The section emphasizes the importance of aligning research oversight with claims handling.

4. Principal investigators

   Reviews supervision and compensation issues tied to the physicians directing clinical studies. It also touches on handling remaining trial funds and avoiding personal benefit concerns.

5. Headhunter fees

   Addresses payments connected to patient enrollment efforts in clinical trials and the disclosure risks that can follow when such arrangements are not transparent.

6. Falsifying trial results

   Describes the compliance and patient-care implications of inaccurate or misleading research results. The section notes the potential downstream impact on payment and accountability concerns.